Related references
Note: Only part of the references are listed.A competing risks regression model for the association between time-varying opioid exposure and risk of overdose
Xingyuan Li et al.
STATISTICAL METHODS IN MEDICAL RESEARCH (2022)
Association of combination opioid, benzodiazepine, and muscle relaxant usage with emergency department visits in a nationwide cohort in the United States
Jonathan Hirohiko Watanabe et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY (2021)
Spontaneous Reports of Serious Adverse Drug Reactions Resulting From Drug-Drug Interactions: An Analysis From the French Pharmacovigilance Database
Louis Letinier et al.
FRONTIERS IN PHARMACOLOGY (2021)
Temporal Trends in Opioid Prescribing Practices in Children, Adolescents, and Younger Adults in the US From 2006 to 2018
Madeline H. Renny et al.
JAMA PEDIATRICS (2021)
Opioid Use and Driving Performance
Keaton T. Cameron-Burr et al.
JOURNAL OF MEDICAL TOXICOLOGY (2021)
The anaesthetist, opioid analgesic drugs, and serotonin toxicity: a mechanistic and clinical review
Brian A. Baldo et al.
BRITISH JOURNAL OF ANAESTHESIA (2020)
Risk of Opioid Overdose Associated With Concomitant Use of Opioids and Skeletal Muscle Relaxants: A Population-Based Cohort Study
Yan Li et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2020)
Opioid Use and the Risk of Falls, Fall Injuries and Fractures among Older Adults: A Systematic Review and Meta-Analysis
Aya Yoshikawa et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2020)
Screening to identify signals of opioid drug interactions leading to unintentional traumatic injury
Charles E. Leonard et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Hospitalization and Combined Use of Opioids, Benzodiazepines, and Muscle Relaxants in the United States
Jonathan H. Watanabe et al.
HOSPITAL PHARMACY (2020)
Competing risks modeling of cumulative effects of time-varying drug exposures
Coraline Danieli et al.
STATISTICAL METHODS IN MEDICAL RESEARCH (2019)
Clopidogrel Drug Interactions and Serious Bleeding: Generating Real-World Evidence via Automated High-Throughput Pharmacoepidemiologic Screening
Charles E. Leonard et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2019)
A Case-Crossover-Based Screening Approach to Identifying Clinically Relevant Drug-Drug Interactions in Electronic Healthcare Data
Katsiaryna Bykov et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2019)
Overlapping prescriptions of opioids, benzodiazepines, and carisoprodol: Holy Trinity prescribing in the state of Florida
Yanning Wang et al.
DRUG AND ALCOHOL DEPENDENCE (2019)
Serotonin Syndrome: Pathophysiology, Clinical Features, Management, and Potential Future Directions
William J. Scotton et al.
INTERNATIONAL JOURNAL OF TRYPTOPHAN RESEARCH (2019)
Role of Opioid-Involved Drug Interactions in Chronic Pain Management
Kevin T. Bain et al.
JOURNAL OF THE AMERICAN OSTEOPATHIC ASSOCIATION (2019)
Population Impact of Drug Interactions with Warfarin: A Real-World Data Approach
Mar Martin-Perez et al.
THROMBOSIS AND HAEMOSTASIS (2018)
PharmGKB summary: oxycodone pathway, pharmacokinetics
Rachel Huddart et al.
PHARMACOGENETICS AND GENOMICS (2018)
An update on the clinical consequences of polypharmacy in older adults: a narrative review
Jonas W. Wastesson et al.
EXPERT OPINION ON DRUG SAFETY (2018)
The Pharmacology and Toxicology of the Holy Trinity'
Joseph T. Horsfall et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2017)
Opioids and Other Central Nervous System-Active Polypharmacy in Older Adults in the United States
Lauren B. Gerlach et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2017)
Patterns of Opioid Use and Risk of Opioid Overdose Death Among Medicaid Patients
Renu K. Garg et al.
MEDICAL CARE (2017)
Pharmacoepidemiologic Methods for Studying the Health Effects of Drug-Drug Interactions
S. Hennessy et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2016)
A New Method to Classify Injury Severity by Diagnosis: Validation Using Workers' Compensation and Trauma Registry Data
Jeanne M. Sears et al.
JOURNAL OF OCCUPATIONAL REHABILITATION (2015)
Atypical Subtrochanteric and Diaphyseal Femoral Fractures: Second Report of a Task Force of the American Society for Bone and Mineral Research
Elizabeth Shane et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2014)
Pharmacoepidemiological assessment of drug interactions with vitamin K antagonists
Anton Pottegard et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2014)
Fractional polynomial adjustment for time-varying covariates in a self-controlled case series analysis
Katherine J. Lee et al.
STATISTICS IN MEDICINE (2014)
Amlodipine Metabolism in Human Liver Microsomes and Roles of CYP3A4/5 in the Dihydropyridine Dehydrogenation
Yanlin Zhu et al.
DRUG METABOLISM AND DISPOSITION (2014)
Opioid Therapies and Cytochrome P450 Interactions
Jeffrey Gudin
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2012)
When should case-only designs be used for safety monitoring of medical products?
Malcolm Maclure et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2012)
Ingestions of Hydrocodone, Carisoprodol, and Alprazolam in Combination Reported to Texas Poison Centers
Mathias B. Forrester
JOURNAL OF ADDICTIVE DISEASES (2011)
Risk of Injury Associated with Opioid Use in Older Adults
David Buckeridge et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2010)
Is there sufficient evidence to suggest cyclobenzaprine might be implicated in causing serotonin toxicity?
P. Ken Gillman
AMERICAN JOURNAL OF EMERGENCY MEDICINE (2009)
Pathologic fractures: should these be included in epidemiologic studies of osteoporotic fractures?
J. R. Curtis et al.
OSTEOPOROSIS INTERNATIONAL (2009)
The methodology of self-controlled case series studies
Heather J. Whitaker et al.
STATISTICAL METHODS IN MEDICAL RESEARCH (2009)
Flexible modeling of the cumulative effects of time-dependent exposures on the hazard
Marie-Pierre Sylvestre et al.
STATISTICS IN MEDICINE (2009)
Tutorial in biostatistics: The self-controlled case series method
Heather J. Whitaker et al.
STATISTICS IN MEDICINE (2006)
Inhibition of CYP2D6 activity by bupropion
M Kotlyar et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2005)